Glimepiride is an oral diabetes medication belonging to the class of sulfonylureas, used to control blood sugar levels in individuals with type 2 diabetes. As a white to yellowish, crystalline powder, it is effective in stimulating the pancreas to produce insulin and enhance the body’s response to insulin, thereby regulating blood glucose levels. Glimepiride acts by binding to specific receptors on pancreatic beta cells, leading to the closure of ATP-dependent potassium channels, which results in calcium influx and subsequent release of insulin. This mechanism helps manage hyperglycemia and improves glycemic control in diabetic patients, aiding in the prevention of complications associated with uncontrolled blood sugar levels.